¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦16ȸ µ¿°è±¹Á¦Çмú´ëȸ : 20-01-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦16ȸ µ¿°è±¹Á¦Çмú´ëȸ : 20-01-11
±³À°ÀÏÀÚ : 2020-01-11
±³À°Àå¼Ò : ¼­¿ï½Å¶óÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ ¿Ü 2°³·ë  
±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦16ȸ µ¿°è±¹Á¦Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212  
À̸ÞÀÏ : grace@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í -Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ: 50,000(»çÀü), 60,000(ÇöÀå)-ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç: 40,000(»çÀü), 50,000(ÇöÀå)-»ê¾÷ü,±âŸ: 100,000(»çÀü), 120,000(ÇöÀå)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 08:00~08:15 IVUS/OCT Study  È«¼ºÁø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 08:15~08:30 Physiologic Study  ÀÌ»ó¿±(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 08:30~08:45 CTO Case  Á¶À翵(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 08:45~09:00 Peripheral/Aorta Case  °íÀ±¼®(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 09:00~09:30 Discussion  () 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 09:30~09:40 Chronic Coronary Syndrome  ½Åµ¿È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 09:40~09:50 Dyslipidemia  ÀÌÀºÁ¤(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 09:50~10:00 The Primary Prevention of Cardiovascular Disease  ±è¼ºÀº(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 10:00~10:10 Anti-thrombotic Therapy in Atrial Fibrillation undergoing PCI  ÀÌÁßÈñ(¿µ³²ÀÇ´ë) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 10:10~10:30 Discussion  () 
±³À°½Ã°£ 01-11 ÅäÆÄÁî(Presentation Arena) 10:30~10:45 Successful Transcatheter Aortic Valve Implantation in a Patient with Severe Aortic Stenosis after the Comprehensive Aortic Root and Valve Repair Surgery  ¹Ú°æÅÃ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-11 ÅäÆÄÁî(Presentation Arena) 10:45~11:00 Case of Successful Endovascular Repair of Huge TAA and Micro-ruptured both CFA Aneurysm  À±¿ø½Ä(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 01-11 ÅäÆÄÁî(Presentation Arena) 11:00~11:15 Recurrent Decompression Sickness even after the Closure of Patent Foramen Ovale in SCUBA Diver  ÀÌÇöÁ¾(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 01-11 ÅäÆÄÁî(Presentation Arena) 11:15~11:30 Filter-based Cerebral Embolic Protection during Transcatheter Aortic Valve Implantation in a High Risk Patient for Stroke  Â÷Á¤ÁØ(¿¬¼¼ÀÇ´ë) 
±âŸ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 11:30~12:00 ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ 2020³â Á¤±âÃÑȸ  () 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 12:00~12:05 Opening  Àå±âÀ°(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 12:05~12:25 Latest Evidence From Ertugliflozin, an SGLT2 Inhibitor for Patients With Type 2 Diabetes  Á¶ÇöÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 12:25~12:45 The benefit of ezetimibe/atorvastatin combination therapy in coronary risk patients with hypercholesterolemia  ³²Ã¢¿í(°è¸íÀÇ´ë) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 12:45~13:00 Discussion  () 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 13:00~13:10 Tips and Trick for Septal Collateral Crossing  ÀÌÀçȯ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 13:10~13:20 Retrograde Approach through Epicardial Collateral Channels  Satoru Otsuji(Higashi Takarazuka Satoh Hospital. Japan) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 13:20~13:30 Epicardial Crossing: How to Perform Safely and Successfully - From European Experiences  Kambis Mashayekhi(University Heartcenter Freiburg-Bad Krozingen. Germany) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 13:30~13:40 Reverse CART Technique  À±Ã¢È¯(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 13:40~13:50 Externalization and Snaring Technique  À̳»Èñ(¼øõÇâÀÇ´ë) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 13:50~14:00 Discussion  () 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 14:00~14:10 1- vs. 2-stent Strategy in Bifurcation Lesions  ¼Û¿µºó(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 14:10~14:20 One Stent Technique in Bifurcation Lesions  ³²Ã¢¿í(°è¸íÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 14:20~14:30 Best 2-stenting Technique in Bifurcation Lesions  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 14:30~14:40 Side Branch Open or Not: Lessons MITO Registry  Sunao Nakamura(New Tokyo Hospital. Japan) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Main Arena) 14:40~15:00 Discussion  () 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 15:00~15:10 Coronary CTA Guided Decision for Selective Invasive CAG: CONSERVE Randomized Study  ¹ÚÇüº¹(°¡Å縯°üµ¿ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 15:10~15:20 Improved Diagnostic Accuracy with CT FFR on the Clinical Impact: ADVANCE Registry  ÀüÀºÁÖ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 15:20~15:30 Enhance Diagnostic Value with CT FMM Assessed Myocardial Mass to Revascularization Decision  ÃÖÁøÈ£(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 15:30~15:40 Impact of CTA Derived Parameters on the Plaque Instability  Á¶Àͼº(Áß¾ÓÀÇ´ë) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 15:40~16:00 Discussion  () 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 16:00~16:10 Pitfalls of TEVAR for Chronic Type B Aortic Dissection  °øÁØÇõ(¸ÞµðÇ÷º½º ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 16:10~16:20 How to Prevent and Manage the Perforation during Peripheral Intervention  ±èÀå¿ë(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 16:20~16:30 Management and Complication of Acute SMA Infarction  ÃÖÀç¿õ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 16:30~16:40 Adult Cardiac Assist Device Related Complications  Daniel H. Kim(University of Alberta & Mazankowski Alberta Heart Institute. Canada) 
Åä·Ð 01-11 ´ÙÀ̳ʽºÆ¼(Symposium Arena) 16:40~17:00 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦16ȸ µ¿°è±¹Á¦Çмú´ëȸ : 20-01-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °è¸í´ëÇб³µ¿»êº´¿ø Single Port Surgery Symposium : 2020-01-11
´ÙÀ½±Û ´ëÇÑôÃß³»½Ã°æ¼ö¼ú¿¬±¸È¸ The 2nd KOSESS Winter Camp and Symposium : 2020-01-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 50 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 36 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 38 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 48 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 39 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 32 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 13 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 13 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 30 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 15 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 14 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 34 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 25 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 30 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 23 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷